Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Valsartan”

376 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 376 results

Post-approval studies (Phase 4)UnknownNCT05060588
What this trial is testing

Sacubitril/Valsartan Versus Valsartan for Hypertensive Patients With Acute Myocardial Infarction

Who this might be right for
Myocardial InfarctionHypertension
Qingdao Central Hospital 200
Early research (Phase 1)Study completedNCT01918358
What this trial is testing

Safety and Pharmacokinetics Between Fixed-dose Combination VR 160/20 mg and Co-administration of Diovan® (Valsartan) Film-coated Tablet 160 mg and Crestor® (Rosuvastatin) 20 mg

Who this might be right for
HypertensionHyperlipidemia
LG Life Sciences 60
Large-scale testing (Phase 3)Study completedNCT01365481
What this trial is testing

Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age

Who this might be right for
HypertensionChronic Kidney Disease
Novartis Pharmaceuticals 150
Not applicableLooking for participantsNCT07347925
What this trial is testing

Effect of Pre-Hospital ARNI Therapy on Short-Term Outcomes in HFrEF

Who this might be right for
Heart Failure
Future University in Egypt 140
Large-scale testing (Phase 3)Study completedNCT00457626
What this trial is testing

Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension

Who this might be right for
Hypertension
Novartis Pharmaceuticals 66
Not applicableLooking for participantsNCT05498675
What this trial is testing

Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study

Who this might be right for
Sacubitril/ValsartanHypertensionObesity
Beijing Friendship Hospital 180
Large-scale testing (Phase 3)Study completedNCT02884206
What this trial is testing

Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction

Who this might be right for
Chronic Heart Failure (CHF)
Novartis Pharmaceuticals 592
Not applicableWithdrawnNCT00627991
What this trial is testing

Blood Pressure Lowering in Acute Stroke Trial (BLAST)

Who this might be right for
Cerebrovascular Accident
Stanford University
Large-scale testing (Phase 3)Enrolling By InvitationNCT06863987
What this trial is testing

A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and Adolescents

Who this might be right for
Essential Hypertension
Shandong New Time Pharmaceutical Co., LTD 342
Post-approval studies (Phase 4)Study completedNCT03990480
What this trial is testing

Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Level

Who this might be right for
Hypertension
Damanhour University 230
Not applicableStudy completedNCT05963282
What this trial is testing

Comparative Effectiveness of Entresto (Sacubitril/Valsartan) Versus ACEi/ARB in de Novo Heart Failure Patients

Who this might be right for
de Novo Heart Failure
Novartis Pharmaceuticals 9,870
Not applicableLooking for participantsNCT03535376
What this trial is testing

Bariatric Surgery and Pharmacokinetics of Valsartan

Who this might be right for
Obesity, Morbid
Norwegian University of Science and Technology 12
Not applicableUnknownNCT00655330
What this trial is testing

Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy

Who this might be right for
Type 2 Diabetes MellitusNephropathy
Guangdong Provincial People's Hospital 170
Post-approval studies (Phase 4)WithdrawnNCT00745953
What this trial is testing

Regression of Fatty Heart by Valsartan Therapy

Who this might be right for
Metabolic SyndromeLipotoxicity
University of Texas Southwestern Medical Center
Large-scale testing (Phase 3)Study completedNCT00696436
What this trial is testing

An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.

Who this might be right for
Hypertension
Takeda 1,291
Early research (Phase 1)UnknownNCT04085627
What this trial is testing

A Bioequivalence Study of Valsartan / Amlodipine From Valsartan and Amlodipine Tablets (Hua Yuan Pharmaceutical LLC, China) and Valsartan and Amlodipine Tablets (Ⅰ) (Novartis Pharma Schweiz AG, Switzerland)

Who this might be right for
Healthy
Second Affiliated Hospital of Wenzhou Medical University 84
Large-scale testing (Phase 3)Study completedNCT00394745
What this trial is testing

Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome

Who this might be right for
HypertensionMetabolic Syndrome
Novartis 45
Post-approval studies (Phase 4)Study completedNCT00171756
What this trial is testing

Study to Compare the Effect of Valsartan vs Atenolol on Pro-thrombotic State in Hypertensive Patients.

Who this might be right for
Hypertension
Novartis 92
Early research (Phase 1)Study completedNCT00839683
What this trial is testing

Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 24
Early research (Phase 1)Study completedNCT00416728
What this trial is testing

Bioavailability of Aliskiren and Valsartan as a Single Tablet vs. the Same Doses of the Two Drugs Given Separately to Healthy Subjects.

Who this might be right for
Healthy
Novartis 32
Next Page